Lenzing Investors Face a Wider Gap Between Plan and Proof After Deutsche Bank's Deep Target Cut
Published on 10/29/2026 at 07:31 | Editorial boerse-global.de
Deutsche Bank Research slashed its price target on Lenzing from EUR 22.00 to EUR 12.70 on Wednesday while keeping a "Hold" rating — a split verdict that captures the central tension in the Austrian fiber maker's equity story. The bank endorses the strategic direction of the turnaround but applies a far harsher valuation yardstick, leaving shareholders to decide whether the plan itself is enough to justify a recovery.
The market, for its part, chose optimism on the day. Lenzing shares climbed 6.9% to EUR 10.62, a snapshot of sentiment rather than evidence of progress on the transformation. A separate 7.4% advance the previous session had already lifted the stock, and neither move says anything definitive about whether the announced measures will translate into better earnings.
Funding Is Settled; Execution Is Not
The clearest hard number in the recent flow of news is the completed capital increase. Lenzing raised EUR 301.2 million by issuing 34,756,362 new shares at EUR 8.65 apiece, a financing event with a quantifiable result that closed roughly a week ago. What it does not do is answer the operating question. A stronger balance sheet and an improved business are two different things, and treating them as one success story is where investors can go wrong.
Ownership structure tells a similar story of activity without proof. Corrected voting-rights filings published this week, reflecting threshold crossings last Friday, showed NN Group at 4.27% and Goldman Sachs Group at 5.86% — up from 4.01% previously. The Goldman position includes financial instruments alongside shares, so it should not be read as outright stock ownership, and neither disclosure amounts to a buy recommendation or a verdict on the turnaround. Following the capital increase's registration on 22 October, the syndicate continues to hold 52.25% of voting rights, a majority that speaks to control rather than profitability.
Should investors sell immediately? Or is it worth buying Lenzing?
The Margin Is the Real Scorecard
At the heart of the transformation sits a targeted EBITDA margin of 20–25%, the most concrete gauge of management's operating ambition. It is a goal, not an achieved state. Lenzing also plans EUR 120 million in additional savings and roughly EUR 150 million in extra EBITDA under the initiative — two distinct pieces of the program, one a cost contribution and one an earnings improvement, neither of which has yet been realized.
Against that backdrop, the loss history weighs heavily. Lenzing has posted net losses since 2022, and a hoped-for EBITDA improvement does not by itself settle the question of a positive bottom line. Equating operating targets with a completed earnings turnaround would be a step too far. The bear case writes itself: a transformation whose earnings impact lags its goals, in which Deutsche Bank's lower valuation carries more weight than its broadly positive view of the restart. An unchanged Hold recommendation is hardly a ringing endorsement of a swift reversal.
What Would Change the Calculus
The bull case begins with delivery. If Lenzing makes the planned relief measures bite, the bank's favorable read on the restart could be confirmed in the numbers, and a strategic intention would gradually harden into a more durable earnings path. The higher Goldman stake, in that scenario, would be a supporting shift in the shareholder base rather than a catalyst in its own right — any re-rating would still have to come from the company, through better returns and traceable progress on savings.
Lenzing at a turning point? This analysis reveals what investors need to know now.
A credible company update on achieved savings or their earnings effect is the next concrete catalyst to watch, with the distinction between restated targets and realized progress mattering more than the size of the headline ambition. Lenzing has scheduled third-quarter 2026 results for 5 November, a date that returns attention to the business figures. Until then, the sober reading holds: the financing is done, the stake disclosures describe ownership, and the operating success story has yet to be proven by the numbers.
Ad
Lenzing Stock: New Analysis - 29 October
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
